Evoke Neuroscience, Inc. — Department of Defense SBIR Phase I: AF192-001
Evoke Neuroscience, Inc. — SBIR Phase I award from Department of Defense.
- Amount
- $49,745
- Agency
- Department of Defense · Air Force
- Program / Phase
- SBIR · Phase I
- Topic
- AF192-001
- Solicitation
- 19.2
- NAICS
- —
- Place of performance
- NY
- Period
- 2019-08-02 → 2020-08-02
Description
The eVox® System, from Evoke Neuroscience, is a medical device that performs a “lab test� for the brain. The eVox® System is an FDA 510(k) cleared Class II medical device intended to acquire, store and display the electrical activity of the brain to aid in diagnosis. The eVox® system could be deployed across the Air Force to provide a standardized data collection/measurement platform providing very precise, objective, and repeatable measurements of brain function to facilitate diagnosis and monitor treatment effectiveness.